Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy

Details for Australian Patent Application No. 2004283299 (hide)

Owner Keck Graduate Institute Alder Biopharmaceuticals, Inc.

Inventors Cregg, James M.; Tolstorukov, Ilya I.; Litton, Mark; Schatzman, Randall; Latham, John

Agent Davies Collison Cave

Pub. Number AU-B-2004283299

PCT Pub. Number WO2005/040395

Priority 60/513,876 22.10.03 US

Filing date 22 October 2004

Wipo publication date 6 May 2005

Acceptance publication date 18 June 2009

International Classifications

C12N 15/74 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/040395 Priority application(s): WO2005/040395

18 June 2009 Application Accepted

  Published as AU-B-2004283299

15 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283300-Immunogenic composition and method of developing a vaccine based on Factor H binding sites

2004283294-Detection of mutations in a gene associated with resistance to viral infection, OAS1